| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679320 | Thrombosis Research | 2018 | 28 Pages |
Abstract
Allogeneic pediatric HSCT patients had higher overall risk of hemorrhagic or thrombotic complications compared to autologous recipients in this study. HSCT for myeloid malignancies was a risk factor for higher complications.
Keywords
TMAVTETTPCR1SOSCMLNIHbusulfanACEHSCTFIBDICVODMESNATBIGvHDAMLWNLdiffuse intravascular coagulationPulmonary embolismantithrombinTotal body irradiationMRIFirst complete remissionEBVCSAVeno-occlusive diseaseVenous thromboembolismVenous thromboembolism (VTE)Thrombotic thrombocytopenic purpuraThrombosisDeep vein thrombosisDVTMagnetic resonance imagingcomputed tomographyThrombotic eventsBleedingHemorrhagewithin normal limitsGastrointestinalSinusoidal obstruction syndromecytomegalovirusCMVHemorrhagic cystitisCyclosporine ACyclophosphamideComplicationsconfidence interval(s)Fibrinogenclottingacute myeloid leukemiaChronic myeloid leukemiaNational Institute of Healththrombotic microangiopathymicromolarodds ratiospolymerase chain reactionPCREpstein barr virusGraft versus host diseaseHematopoietic stem cell transplantChildren
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dominder Kaur, Aneel A. Ashrani, Rajiv Pruthi, Shakila P. Khan, Kent Bailey, Vilmarie Rodriguez,